Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations.

Journal: BMC medicine

Volume: 18

Issue: 1

Year of Publication: 

Affiliated Institutions:  WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy. giovanni.ostuzzi@univr.it. WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy. Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA. Department of Molecular Medicine, University of Siena, Siena, Italy. Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg Campus, Cape Town, , South Africa. Azienda ULSS Scaligera, Verona, Italy. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan. Department of Psychiatry, University of Alberta, Edmonton, Alberta, Canada. Department of Psychological Medicine, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK. Pharmacy Department, Maudsley Hospital, London, UK. Centre for Global Mental Health and Centre for Implementation Science, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. School of Psychiatry, UNSW Sydney and Schizophrenia Research Unit, Ingham Institute of Applied Medical Research, Liverpool, NSW, Australia. Department of Psychiatry and Psychotherapy, University Medical Center of Mainz, Mainz, Germany.

Statistics

Identifiers

Study Population

Mesh Terms

Other Terms

Study Design

Study Approach

Country of Study

Publication Country